Lineage Cell Therapeutics
LCTX
#8829
Rank
NZ$0.19 B
Marketcap
$0.86
Share price
-0.62%
Change (1 day)
-49.34%
Change (1 year)

Lineage Cell Therapeutics (LCTX) - Cash on Hand

Cash on Hand as of September 2024 : NZ$56.92 Million

According to Lineage Cell Therapeutics 's latest financial reports the company has NZ$56.92 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Lineage Cell Therapeutics - Cash on Hand chart (from 1996 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31NZ$56.12 M-38.43%
2022-12-31NZ$91.15 M6.69%
2021-12-31NZ$85.43 M48.33%
2020-12-31NZ$57.6 M26.3%
2019-12-31NZ$45.6 M-0.48%
2018-12-31NZ$45.82 M-14.74%
2017-12-31NZ$53.75 M63.92%
2016-12-31NZ$32.79 M-47.78%
2015-12-31NZ$62.8 M66.85%
2014-12-31NZ$37.63 M462.82%
2013-12-31NZ$6.68 M26.47%
2012-12-31NZ$5.28 M-81.42%
2011-12-31NZ$28.46 M-34.11%
2010-12-31NZ$43.19 M157.39%
2009-12-31NZ$16.78 M79212.77%
2008-12-31NZ$0.02 M70.59%
2007-12-31NZ$0.01 M-98.44%
2006-12-31NZ$0.79 M-70.32%
2005-12-31NZ$2.68 M39.66%
2004-12-31NZ$1.92 M74.12%
2003-12-31NZ$1.1 M-55.05%
2002-12-31NZ$2.45 M-38.34%
2001-12-31NZ$3.98 M33.79%
2000-12-31NZ$2.97 M-70.63%
1999-12-31NZ$10.12 M122.39%
1998-12-31NZ$4.55 M
1998-06-30NZ$7.88 M-31.36%
1997-06-30NZ$11.48 M227.68%
1996-06-30NZ$3.5 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NZ$0.47 B 732.65%๐Ÿ‡บ๐Ÿ‡ธ USA